About the journal
- Does Beta-Blocker Therapy Reduce the Cardiovascular Benefit of Aerobic Exercise in Patients with Arterial Hypertension?
- Mechanisms Connecting Diabetes Mellitus and Obesity
- Documented Cardiovascular Benefit of Empagliflozin in New American Diabetes Treatment Guidelines
- DPP4 Inhibitors in Chronic Kidney Disease and Their Potential to Protect Against Diabetic Nephropathy